Literature DB >> 1664131

The mouse model and understanding immunity to herpes simplex virus.

J C Mester1, B T Rouse.   

Abstract

Investigation of the immune response to herpes simplex virus (HSV) has progressed rapidly, mainly through the use of various animal models of human disease. Murine models of HSV infection have been explored extensively and have yielded a wide array of insights into the mechanisms of antiviral immunity. Current research has focused on defining the role of individual viral envelope glycoproteins in stimulating a protective B and T cell response, with the ultimate goal of identifying the minimum effective immunization unit. This ongoing dissection of the glycoprotein-specific immune response in the mouse has revealed both the values of an animal model that mimics human infection and the limitations inherent in defining the immunopotential of specific viral proteins and peptides in an unnatural host. This article reviews the results of murine studies evaluating the mechanisms of protection against HSV infection and the protective potential of immunization with the viral envelope glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664131     DOI: 10.1093/clind/13.supplement_11.s935

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

Review 1.  Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Authors:  P P Sanna; D R Burton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis.

Authors:  K L Tyler; M A Mann; B N Fields; H W Virgin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

3.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

Authors:  K Ahn; T H Meyer; S Uebel; P Sempé; H Djaballah; Y Yang; P A Peterson; K Früh; R Tampé
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

Review 4.  Immunopathogenesis of herpetic ocular disease.

Authors:  J Thomas; B T Rouse
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response.

Authors:  Diethilde Theil; Tobias Derfuss; Igor Paripovic; Simone Herberger; Edgar Meinl; Olaf Schueler; Michael Strupp; Viktor Arbusow; Thomas Brandt
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

6.  Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.

Authors:  L A Morrison; D M Knipe
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice.

Authors:  K Ikemoto; T Utsunomiya; M A Ball; M Kobayashi; R B Pollard; F Suzuki
Journal:  Experientia       Date:  1994-05-15

8.  Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.

Authors:  L A Salvucci; R H Bonneau; S S Tevethia
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Permissive and restricted virus infection of murine embryonic stem cells.

Authors:  Rachael Wash; Sabrina Calabressi; Stephanie Franz; Samantha J Griffiths; David Goulding; E-Pien Tan; Helen Wise; Paul Digard; Jürgen Haas; Stacey Efstathiou; Paul Kellam
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

Review 10.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.